FibroBiologics, Inc. Common Stock (FBLG) Financials
FBLG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 5.9 million | 3.3 million |
| Dec. 31, 2025 | 9.6 million | 3.5 million |
| Sept. 30, 2025 | 8.7 million | 8.6 million |
| June 30, 2025 | 13.9 million | 13.0 million |
FBLG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -4.4 million | 694000 |
| Dec. 31, 2025 | -3.2 million | 702000 |
| Sept. 30, 2025 | -4.0 million | 704000 |
| June 30, 2025 | -4.2 million | 729000 |
FBLG Net Income
No data available :(
FBLG Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 1.5 million | 1.5 million | 2.2 million |
| Dec. 31, 2025 | 4.9 million | 1.7 million | 2.4 million |
| Sept. 30, 2025 | 4.9 million | 1.9 million | 2.5 million |
| June 30, 2025 | 8.8 million | - | 2.7 million |
FBLG Shares Outstanding
FBLG Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.0 million | 2.1 million | - |
| Dec. 31, 2025 | - | 797000 | 1.8 million | - |
| Sept. 30, 2025 | 6000 | 2.8 million | 2.2 million | - |
| June 30, 2025 | 213000 | 2.0 million | 2.4 million | - |
FBLG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 234000 |
| Sept. 30, 2025 | - | 231000 |
| June 30, 2025 | - | 206000 |
FBLG
Price: $0.77
52 week price:
Earnings Per Share: -7.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 million